Michael Carrier Profile
Michael Carrier

@profmikecarrier

Followers
2K
Following
3K
Media
6
Statuses
6K

Professor at Rutgers Law School specializing in antitrust and IP law. @[email protected]; @mcarrier.bsky.social

Joined March 2013
Don't wanna be here? Send us removal request.
@MarcEdelman
Marc Edelman
1 year
Forthcoming in @FordhamLRev: "Of Labor, Antitrust and Why the Proposed House Settlement Will Not Solve the NCAA's Problem." Co-authored with @profmikecarrier, which is always a pleasure. https://t.co/YT98E2Kmwz
1
6
18
@MarcEdelman
Marc Edelman
1 year
So, the #NCAA is again thinking about reducing the time of its football transfer portal without engaging in collective bargaining. Is this an #antitrust risk? Predictably, @profmikecarrier and I have already addressed this issue:
3
6
19
@MarcEdelman
Marc Edelman
1 year
Glad to see heightened antitrust enforcement in sports and sports-adjacent areas. My friend and frequent co-author, @profmikecarrier, recently published an article on anticompetitive conduct in event ticketing.
@JusticeATR
Antitrust Division
1 year
Ten Additional States Join Justice Department’s Suit Against Live Nation-Ticketmaster for Monopolizing Markets Across the Live Concert Industry 🔗: https://t.co/7S2gtbd896
0
1
5
@McCannSportsLaw
Michael McCann
1 year
Happy birthday to the man who made NIL possible: @Ed_OBannon. Ed fought for college athletes to have the same rights as their classmates and other Americans. He won.
1
6
64
@profmikecarrier
Michael Carrier
1 year
Excited to announce a new IP Certificate program at @RutgersLaw!
0
2
5
@katie_eyer
Katie Eyer
1 year
We're hiring at Rutgers Law School! This position is in our Camden location, just across the river from Philadelphia. Our focus is on candidates with scholarly and teaching interests in Tax, Business Organizations, Contracts and/or Constitutional Law. We are interested in both
0
20
32
@profmikecarrier
Michael Carrier
1 year
Some have blamed the Supreme Court for a lack of clarity in the law of “pay-for-delay” agreements. After reviewing all of these cases in the past decade, Ed Bank & I explain how the law hasn’t fully developed because the vast majority of the cases settle.
0
1
6
@FanFairness
Fan Fairness Coalition
1 year
Fans deserve a better experience than Ticketmaster’s faulty platform. We agree with the DOJ and experts across the country–it’s time to break up #LiveNation-#Ticketmaster. Enough said. *Mic drop*
0
1
2
@PGunigantiAT
Pallavi Guniganti
1 year
One of the better analyses of U.S. v Live Nation / Ticketmaster I’ve seen — assesses the #antitrust complaint thoroughly instead of just #breakemup
@profmikecarrier
Michael Carrier
1 year
And here are some highlights from the complaint: https://t.co/cH3X8l0sfp
1
1
1
@IMAKglobal
Initiative for Medicines, Access & Knowledge
1 year
📅Tomorrow at 12PM ET! @realtahiramin, @profmikecarrier, @AlexHMoss and @RSI’s Wayne Brough will discuss patent policy, how patents impact drug prices, and why we desperately need to rethink our patent system. RSVP to join ⤵️ https://t.co/Uelqp5zpfD
Tweet card summary image
rstreet.org
Featuring [Moderator] Wayne Brough, Policy Director, Technology and Innovation, R Street Institute Michael Carrier, Board of Governors Professor, Rutgers Law School Alex Moss, Executive Director,...
0
3
6
@RSI
R Street Institute
1 year
📆 June 25 on the Hill: Balancing Innovation and Accessibility: Reforming Patent Policy for Patient Benefit https://t.co/S0GeX1kECP with our Wayne Brough, @realtahiramin @IMAKglobal, @profmikecarrier @RutgersLaw, Alex Moss @PublicPatent
0
1
3
@profmikecarrier
Michael Carrier
1 year
Glad to see NCAA will stop enforcing transfer rules. @MarcEdelman and I explained why they violate antitrust law:
0
4
6
@GlobalDiaBEATes
Merith Basey MSc
2 years
Is Congress pivoting to more bipartisan ground? There's widespread agreement that pharmaceutical companies have gamed the system to keep prices high for patients. It's time for reform and we will keep pushing! @p4adnow
Tweet card summary image
axios.com
There's bipartisan support for cracking down on pharma's gaming of the patent system.
0
3
4
@profmikecarrier
Michael Carrier
2 years
Excellent discussion of the harms from product hopping and of bipartisan legislation that could address this.
@Avik
Avik Roy
2 years
New from me @Forbes: How drug companies unlawfully stifle generic competition with "product hopping."
0
0
2